Works matching IS 02780232 AND DT 2021 AND VI 39 AND IP 3


Results: 21
    1

    Erratum.

    Published in:
    2021
    Publication type:
    Correction Notice
    2

    Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 326, doi. 10.1002/hon.2861
    By:
    • Rigolin, Gian Matteo;
    • Cavazzini, Francesco;
    • Piciocchi, Alfonso;
    • Arena, Valentina;
    • Visentin, Andrea;
    • Reda, Gianluigi;
    • Zamprogna, Giulia;
    • Cibien, Francesca;
    • Vitagliano, Orsola;
    • Coscia, Marta;
    • Farina, Lucia;
    • Gaidano, Gianluca;
    • Murru, Roberta;
    • Varettoni, Marzia;
    • Paolini, Rossella;
    • Sportoletti, Paolo;
    • Pietrasanta, Daniela;
    • Molinari, Anna Lia;
    • Quaglia, Francesca M.;
    • Laurenti, Luca
    Publication type:
    Article
    3

    Mesenchymal stem cells enhance the impact of KIR receptor‐ligand mismatching on acute graft‐versus‐host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 380, doi. 10.1002/hon.2867
    By:
    • Zhang, Yu;
    • Zheng, Hao;
    • Ren, Jinhua;
    • Luo, Xiaofeng;
    • Zheng, Zhihong;
    • Zheng, Jing;
    • Zheng, Xiaoyun;
    • Chen, Yi;
    • Chen, Zhizhe;
    • Hu, Jianda;
    • Yang, Ting
    Publication type:
    Article
    4

    Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 401, doi. 10.1002/hon.2851
    By:
    • Latagliata, Roberto;
    • Attolico, Immacolata;
    • Trawinska, Malgorzata Monika;
    • Capodanno, Isabella;
    • Annunziata, Mario;
    • Elena, Chiara;
    • Luciano, Luigiana;
    • Crugnola, Monica;
    • Bergamaschi, Micaela;
    • Bonifacio, Massimiliano;
    • Baratè, Claudia;
    • Mauro, Endri;
    • Binotto, Gianni;
    • Sgherza, Nicola;
    • Aguzzi, Chiara;
    • Monteleone, Barbara;
    • Sorà, Federica;
    • Caocci, Giovanni;
    • Luzi, Debora;
    • Mariggiò, Elena
    Publication type:
    Article
    5
    6

    Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 293, doi. 10.1002/hon.2864
    By:
    • Genuardi, Elisa;
    • Klous, Petra;
    • Mantoan, Barbara;
    • Drandi, Daniela;
    • Ferrante, Martina;
    • Cavallo, Federica;
    • Alessandria, Beatrice;
    • Dogliotti, Irene;
    • Grimaldi, Daniele;
    • Ragaini, Simone;
    • Clerico, Michele;
    • Lo Schirico, Mariella;
    • Saraci, Elona;
    • Yilmaz, Mehmet;
    • Zaccaria, Gian Maria;
    • Cortelazzo, Sergio;
    • Vitolo, Umberto;
    • Luminari, Stefano;
    • Federico, Massimo;
    • Boccadoro, Mario
    Publication type:
    Article
    7

    Erratum.

    Published in:
    2021
    Publication type:
    Correction Notice
    8
    9
    10

    Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 349, doi. 10.1002/hon.2863
    By:
    • Takakuwa, Teruhito;
    • Ohta, Kensuke;
    • Nakatani, Eiji;
    • Ito, Tomoki;
    • Kaneko, Hitomi;
    • Fuchida, Shin‐Ichi;
    • Shimura, Yuji;
    • Yagi, Hideo;
    • Shibayama, Hirohiko;
    • Kanda, Junya;
    • Uchiyama, Hitoji;
    • Kosugi, Satoru;
    • Tanaka, Hirokazu;
    • Kawata, Eri;
    • Uoshima, Nobuhiko;
    • Ishikawa, Jun;
    • Shibano, Masaru;
    • Karasuno, Takahiro;
    • Shindo, Maki;
    • Shimizu, Yoshifumi
    Publication type:
    Article
    11
    12
    13

    Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 409, doi. 10.1002/hon.2843
    By:
    • Benevolo, Giulia;
    • Elli, Elena M.;
    • Bartoletti, Daniela;
    • Latagliata, Roberto;
    • Tiribelli, Mario;
    • Heidel, Florian H.;
    • Cavazzini, Francesco;
    • Bonifacio, Massimiliano;
    • Crugnola, Monica;
    • Binotto, Gianni;
    • D'Addio, Alessandra;
    • Tieghi, Alessia;
    • Bergamaschi, Micaela;
    • Caocci, Giovanni;
    • Polverelli, Nicola;
    • Bossi, Elisa;
    • Auteri, Giuseppe;
    • Carmosino, Ida;
    • Catani, Lucia;
    • Cuneo, Antonio
    Publication type:
    Article
    14

    Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 336, doi. 10.1002/hon.2842
    By:
    • Dimou, Maria;
    • Papageorgiou, Sotirios G.;
    • Stavroyianni, Niki;
    • Katodritou, Eirini;
    • Tsirogianni, Maria;
    • Kalpadakis, Christina;
    • Banti, Anastasia;
    • Arapaki, Maria;
    • Iliakis, Theodoros;
    • Bouzani, Maria;
    • Verrou, Eugenia;
    • Spanoudakis, Emmanouil;
    • Giannouli, Stavroula;
    • Marinakis, Theodoros;
    • Mandala, Evdokia;
    • Mparmparousi, Despoina;
    • Sachanas, Sotirios;
    • Dalekou‐Tsolakou, Maria;
    • Hatzimichael, Eleftheria;
    • Vadikolia, Chryssa
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Issue Information.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 3, p. 273, doi. 10.1002/hon.2747
    Publication type:
    Article
    21